Publications Pre-2000

Grasela TH, Antal EJ, Fiedler-Kelly J, Foit DJ, Barth B, Knuth DW, Carel BJ, Cox SR. An Automated Drug Concentration Screening and quality Assurance Program for Clinical Trials. Drug Information Journal. 1999;33:273-9.

Grasela TH, Fiedler-Kelly J, Cox E, Womble GP, Risner ME, Chen C. Population Pharmacokinetics Of Lamotrigine Adjunctive Therapy In Adults With Epilepsy. J Clin Pharmacol. 1999;39(4):373-84.

Wang EC, Grasela TH, Walawander CA. Applying Epidemiology-Based Outcomes Research to Clinical Decision-Making. A Hypothetical Model of Biotechnology Therapy in Gram-Negative Sepsis. Pharmacoeconomics. 1999;15(4):385-93.

Fleishaker JC, Fiedler-Kelly J, Grasela TH. Population Pharmacokinetics Of Tirilazad: Effects Of Weight, Gender, Concomitant Phenytoin, And Subarachnoid Hemorrhage. Pharm Res. 1999;16(4):575-83.

Adams JM, Shelton MJ, Hewitt RG, Grasela TH, DeRemer M, Morse GD. Relationship Between Didanosine Exposure And Surrogate Marker Response In Human Immunodeficiency Virus-Infected Outpatients. Antimicrob Agents Chemother. 1998;42(4):821-6.

Meyer CC, Calis KA, Burke LB, Walawander CA, Grasela TH. Symptomatic Cardiotoxicity Associated With 5-Fluorouracil. Pharmacotherapy. 1997;17(4):729-36.

Schmith VD, Fiedler-Kelly J, Phillips L, Grasela TH Jr. Prospective Use Of Population Pharmacokinetics/Pharmacodynamics In The Development Of Cisatracurium. Pharm Res. 1997;14(1):91-7.

Schmith VD, Fiedler-Kelly J, Phillips L, Grasela TH Jr. Dose Proportionality Of Cisatracurium. J Clin Pharmacol. 1997;37(7):625-9.